Markets:

Overview

News

Currencies

International

Treasuries

Simplify Health Care ETF (NY:PINK)

38.97 +0.33 (+0.84%)

Official Closing Price Updated: 8:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Simplify Health Care ETF

Better Healthcare ETF: iShares Biotechnology-Focused IBB vs. Simplify's Broad PINK ↗

September 25, 2026

iShares offers lower fees and concentrated biotech exposure with stronger 1-year returns, while Simplify provides broader healthcare diversification and a higher dividend yield.

Via The Motley Fool

Topics ETFs

Vanguard Health Care ETF vs Simplify Health Care ETF ↗

September 01, 2026

Vanguard offers broad exposure at 0.09% cost with 1.5% yield, while Simplify's active strategy returned 32.4% over one year but charges 0.51%.

Via The Motley Fool

Topics ETFs

Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now? ↗

August 13, 2026

Active management and a charitable mission drive Simplify's 42% gain, but iShares offers lower costs and higher dividend income for conservative investors.

Via The Motley Fool

Topics ETFs

UNH Stock Slides Pre-Market: United Health Warns Of Softer FY26 As Medicare Pressures Mount ↗

January 27, 2026

Via Stocktwits

Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or Simplify's Actively Managed PINK? ↗

August 13, 2026

Fidelity's broad, low-cost index approach goes head-to-head with an actively managed, mission-driven healthcare fund.

Via The Motley Fool

Topics ETFs

This Healthcare ETF Is Outperforming the Invesco Equal Weight Fund -- and It Offers a Charitable Twist ↗

August 13, 2026

Active management and concentrated bets drove a 42% one-year return, though the lower-cost Invesco alternative offers broader diversification across 60 healthcare stocks.

Via The Motley Fool

Topics ETFs

PINK vs. XLV: How Do These Two Health Care ETFs Match Up? ↗

July 26, 2026

PINK outperformed XLV by 8.7 percentage points over one year, but carries higher fees and volatility. XLV offers lower costs and a higher dividend yield for passive healthcare exposure.

Via The Motley Fool

Topics ETFs

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors? ↗

July 22, 2026

PINK has stronger one-year and three-year returns, while IXJ offers lower costs and a higher dividend yield.

Via The Motley Fool

Topics ETFs

Market-Weighted Healthcare or Active Manager Selection? IYH vs. PINK ↗

June 18, 2026

The iShares U.S. Healthcare ETF (IYH) tracks a broad healthcare index, while the Simplify Health Care ETF (PINK) gives an active manager more room to choose. That difference matters for investors...

Via The Motley Fool

Topics ETFs

iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns ↗

June 10, 2026

One fund channels profits to breast cancer research, while the other focuses on established drugmakers. See how their strategies shape risk and sector exposure.

Via The Motley Fool

Topics ETFs

Healthcare Giants or Medical Innovators? XLV and PINK Are Built for Different Investors. ↗

June 05, 2026

One fund backs medical breakthroughs and charity, while the other favors industry giants and steady income. Compare their strategies and portfolio makeup.

Via The Motley Fool

Topics ETFs

Vanguard (VHT) Vs. Simplify (PINK): Which Healthcare ETF Is the Better Buy for Investors? ↗

June 02, 2026

Explore how two healthcare ETFs stack up in cost, yield, and strategy, with one fund emphasizing innovation and charitable impact.

Via The Motley Fool

Topics ETFs

Beyond Oil And Gold: Can We Expect A Surge In 'Crisis Alpha' ETFs Amid Israel-Iran Tensions? ↗

June 13, 2025

Middle East conflict boosts demand for 'crisis alpha' ETFs in defense, energy, inflation, and cybersecurity sectors, as investors fear market volatility.

Via Benzinga

Topics ETFs Economy

Biohaven Rallies On Heels Of $600M Funding Agreement With Oberland ↗

April 28, 2025

Biohaven Ltd. (BHVN) shares rise premarket as it secures up to $600 million investment from Oberland Capital. Cash reserves expected to reach $489 million.

Via Benzinga

Leap Therapeutics Stock Plunges To Record Low After Ending Gastric Cancer Drug Trials, Retail Bets On CRC Pipeline ↗

January 28, 2025

While sirexatamab combined with tislelizumab and chemotherapy showed some activity in biomarker-specific populations, the study failed to generate a clear positive signal on progression-free survival...

Via Stocktwits

World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements ↗

January 22, 2025

Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.

Via Benzinga

Topics Government

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 ↗

December 29, 2023

According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.